vs
Side-by-side financial comparison of EyePoint, Inc. (EYPT) and Intellicheck, Inc. (IDN). Click either name above to swap in a different company.
Intellicheck, Inc. is the larger business by last-quarter revenue ($6.6M vs $5.3M, roughly 1.2× EyePoint, Inc.). Intellicheck, Inc. runs the higher net margin — 23.4% vs -1114.3%, a 1137.7% gap on every dollar of revenue. On growth, Intellicheck, Inc. posted the faster year-over-year revenue change (11.8% vs -43.7%). Intellicheck, Inc. produced more free cash flow last quarter ($2.4M vs $-63.8M). Over the past eight quarters, Intellicheck, Inc.'s revenue compounded faster (19.1% CAGR vs -40.8%).
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Intellicheck, Inc. is a US-based technology company specializing in identity verification and fraud prevention solutions. It develops AI-powered tools to validate government-issued identification documents, streamline customer onboarding, and mitigate identity theft risks for clients across finance, retail, healthcare and public sector segments.
EYPT vs IDN — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.3M | $6.6M |
| Net Profit | $-59.4M | $1.6M |
| Gross Margin | — | 91.4% |
| Operating Margin | -1166.8% | 22.5% |
| Net Margin | -1114.3% | 23.4% |
| Revenue YoY | -43.7% | 11.8% |
| Net Profit YoY | -92.8% | 218.0% |
| EPS (diluted) | $-0.85 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $6.6M | ||
| Q3 25 | — | $6.0M | ||
| Q2 25 | $5.3M | $5.1M | ||
| Q1 25 | $24.5M | $4.9M | ||
| Q4 24 | $11.6M | $5.9M | ||
| Q3 24 | $10.5M | $4.7M | ||
| Q2 24 | $9.5M | $4.7M | ||
| Q1 24 | $11.7M | $4.7M |
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $290.0K | ||
| Q2 25 | $-59.4M | $-251.0K | ||
| Q1 25 | $-45.2M | $-318.0K | ||
| Q4 24 | $-41.4M | $488.0K | ||
| Q3 24 | $-29.4M | $-837.0K | ||
| Q2 24 | $-30.8M | $-127.0K | ||
| Q1 24 | $-29.3M | $-442.0K |
| Q4 25 | — | 91.4% | ||
| Q3 25 | — | 90.5% | ||
| Q2 25 | — | 89.8% | ||
| Q1 25 | — | 89.7% | ||
| Q4 24 | — | 91.1% | ||
| Q3 24 | 93.0% | 91.0% | ||
| Q2 24 | 85.2% | 90.5% | ||
| Q1 24 | 93.5% | 90.7% |
| Q4 25 | — | 22.5% | ||
| Q3 25 | — | 4.0% | ||
| Q2 25 | -1166.8% | -5.8% | ||
| Q1 25 | -199.7% | -7.1% | ||
| Q4 24 | -390.4% | 8.1% | ||
| Q3 24 | -311.2% | -19.3% | ||
| Q2 24 | -364.5% | -4.6% | ||
| Q1 24 | -285.2% | -11.2% |
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | -1114.3% | -4.9% | ||
| Q1 25 | -184.8% | -6.5% | ||
| Q4 24 | -357.3% | 8.2% | ||
| Q3 24 | -279.0% | -17.8% | ||
| Q2 24 | -325.3% | -2.7% | ||
| Q1 24 | -250.6% | -9.4% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | $-0.85 | $-0.01 | ||
| Q1 25 | $-0.65 | $-0.02 | ||
| Q4 24 | $-0.65 | $0.02 | ||
| Q3 24 | $-0.54 | $-0.04 | ||
| Q2 24 | $-0.58 | $-0.01 | ||
| Q1 24 | $-0.55 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $255.7M | $9.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.0M | $20.7M |
| Total Assets | $301.1M | $24.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $7.2M | ||
| Q2 25 | $255.7M | $8.6M | ||
| Q1 25 | $318.2M | $5.1M | ||
| Q4 24 | $370.9M | $4.7M | ||
| Q3 24 | $253.8M | $5.7M | ||
| Q2 24 | $280.2M | $7.3M | ||
| Q1 24 | $299.3M | $9.2M |
| Q4 25 | — | $20.7M | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | $246.0M | $18.0M | ||
| Q1 25 | $298.4M | $17.6M | ||
| Q4 24 | $336.5M | $17.7M | ||
| Q3 24 | $218.7M | $16.7M | ||
| Q2 24 | $228.3M | $17.3M | ||
| Q1 24 | $249.9M | $17.2M |
| Q4 25 | — | $24.5M | ||
| Q3 25 | — | $25.3M | ||
| Q2 25 | $301.1M | $23.1M | ||
| Q1 25 | $362.6M | $24.6M | ||
| Q4 24 | $418.5M | $20.9M | ||
| Q3 24 | $300.9M | $20.7M | ||
| Q2 24 | $324.2M | $21.9M | ||
| Q1 24 | $329.2M | $22.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-62.6M | $2.4M |
| Free Cash FlowOCF − Capex | $-63.8M | $2.4M |
| FCF MarginFCF / Revenue | -1196.5% | 36.0% |
| Capex IntensityCapex / Revenue | 22.9% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.54× |
| TTM Free Cash FlowTrailing 4 quarters | $-194.0M | $4.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $-1.7M | ||
| Q2 25 | $-62.6M | $3.1M | ||
| Q1 25 | $-53.1M | $750.0K | ||
| Q4 24 | $-35.8M | $-1.3M | ||
| Q3 24 | $-39.0M | $-1.1M | ||
| Q2 24 | $-20.2M | $-1.2M | ||
| Q1 24 | $-31.2M | $869.0K |
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | $-63.8M | $3.1M | ||
| Q1 25 | $-53.4M | $741.0K | ||
| Q4 24 | $-36.2M | $-1.3M | ||
| Q3 24 | $-40.6M | $-1.1M | ||
| Q2 24 | $-21.1M | $-1.2M | ||
| Q1 24 | $-32.4M | $860.0K |
| Q4 25 | — | 36.0% | ||
| Q3 25 | — | -29.2% | ||
| Q2 25 | -1196.5% | 60.9% | ||
| Q1 25 | -218.4% | 15.1% | ||
| Q4 24 | -312.7% | -22.4% | ||
| Q3 24 | -385.8% | -23.1% | ||
| Q2 24 | -222.4% | -25.5% | ||
| Q1 24 | -277.0% | 18.4% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | 22.9% | 0.3% | ||
| Q1 25 | 1.1% | 0.2% | ||
| Q4 24 | 3.3% | 0.2% | ||
| Q3 24 | 15.0% | 0.6% | ||
| Q2 24 | 9.5% | 0.2% | ||
| Q1 24 | 10.2% | 0.2% |
| Q4 25 | — | 1.54× | ||
| Q3 25 | — | -5.99× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.71× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
